Epifast 500mg Tablet contains Levetiracetam, an antiepileptic medication indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in adults and pediatric patients. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and preventing seizure propagation. Epifast is typically administered orally, with dosage individualized based on patient age, renal function, and clinical response. It is well tolerated, with common adverse effects including somnolence, dizziness, headache, and behavioral changes such as irritability or mood swings. Caution is advised in patients with a history of psychiatric disorders or renal impairment, necessitating dose adjustments. Epifast does not induce or inhibit hepatic enzymes significantly, minimizing drug-drug interactions, although concurrent use with other antiepileptics should be monitored. Regular clinical evaluation and therapeutic monitoring are recommended to optimize seizure control and minimize side effects. Epifast should be discontinued gradually to avoid withdrawal seizures. This medication is contraindicated in patients with known hypersensitivity to Levetiracetam or any excipients. Epifast 500mg Tablet offers an effective and well-tolerated option for seizure management within a comprehensive epilepsy treatment plan.